At the top of Jim Cramer's Tuesday night Mad Money program, he pointed out Regeneron Pharmaceuticals (REGN) to viewers. Regeneron rose 6% Tuesday as bioscience continues to power higher on American ingenuity. Let's check the charts of this biotech company that invents life-transforming medicines for people with serious diseases.
More from Investing
How the battle of value vs. growth stocks is resolved, we will have to wait and see.
JWN is not a retail name that looks constructive.
Here's our latest analysis and trading strategy for this retail name.
This one doesn't have options, so it would be a pure stock play now.